Biontech

268 results

Paul Reid of Pfizer is taking over as head of industry body Ipha. Photograph: Dara Mac Dónaill / The Irish Times

“What we want to do is correct the innovation paradox...” It’s a bad start to an interview and a raised eyebrow persuades Paul Reid to explain the man(...)

Greencoat Renewables shed 1.68 per cent of its value to close at €1.17. Photograph: Dara Mac Dónaill

World stock markets rose yesterday on encouraging signs of progress in developing a Covid-19 vaccine, while several multibillion-dollar deals also hel(...)

The difficulty for vaccine makers is that even clinical trials involving 30,000 people – such as AstraZeneca’s current phase 3 trial – may not pick up rare, but potentially devastating, reactions. Photograph: iStock

When AstraZeneca confirmed on Tuesday evening that it had temporarily halted trials of its coronavirus vaccine, the news disconcerted millions around(...)

Photograph: iStock

AstraZeneca has paused global trials, including large late-stage trials, of its experimental coronavirus vaccine due to an unexplained illness in a st(...)

Photograph: iStock

Nine leading US and European vaccine developers pledged on Tuesday to uphold the scientific standards their experimental immunisations will be held ag(...)

US pharma companies Moderna and Pfizer, with its German partner BioNTech have launched major Phase III trials of their Covid vaccine candidates. Photograph: Hans Pennink/AP

German biotech BioNTech and US drugmaker Pfizer will begin a pivotal global study of 30,000 people to evaluate their lead Covid-19 vaccine candidate. (...)

Banks, while also reversing gains, underperformed the wider market on the day. Photograph: Dara Mac Dónaill

European shares slid on Wednesday as escalating US-China tensions and a surge in coronavirus cases dented sentiment after an EU-wide debt deal sent th(...)

The US government has signed a $1.95 billion deal to secure access to 100 million doses of a Covid vaccine being developed by German company BioNTech in association with Pfizer.  Photograph: David Cheskin/PA Wire

The US government has signed a $1.95 billion deal to secure access to 100 million doses of a Covid vaccine being developed by German company BioNTech (...)

In London AstraZeneca hit a record closing high on optimism over its Covid-19 vaccine. Photograph: Paul Ellis/AFP via Getty

European shares turned higher on Monday, helped by encouraging data from an array of coronavirus vaccine candidates and after EU leaders sketched a fr(...)

Results of phase 1 trials suggest the vaccine triggers two types of immune response. Photograph: EPA

The first human trials of a Covid-19 vaccine being developed by researchers at the University of Oxford suggest it is safe and triggers two types of i(...)

  • « First
  • Prev
  • 23
  • 24
  • 25
  • 26
  • 27
  • Next
  • Last »